4//SEC Filing
Holtzman Douglas 4
Accession 0001209191-22-044021
CIK 0001786255other
Filed
Aug 1, 8:00 PM ET
Accepted
Aug 2, 9:42 PM ET
Size
11.7 KB
Accession
0001209191-22-044021
Insider Transaction Report
Form 4
Icosavax, Inc.ICVX
Holtzman Douglas
Chief Scientific Officer
Transactions
- Sale
Common Stock
2022-08-02$6.70/sh−453$3,037→ 293,258 total - Sale
Common Stock
2022-08-01$6.64/sh−9,337$61,973→ 293,711 total - Gift
Common Stock
2022-02-18−20,000→ 22,440 total(indirect: By Stanley Holtzman) - Sale
Common Stock
2022-07-29$7.11/sh−585$4,158→ 303,048 total
Footnotes (6)
- [F1]Represents shares withheld by the Reporting Person pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person to cover the withholding taxes upon settlement of restricted stock units issued to the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.93 to $7.75. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]Also includes the sale of 7,666 shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 16, 2021.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.38 to $7.17. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.460 to $6.865. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F6]Douglas Holtzman, Ph.D. holds power-of-attorney (POA) over the shares owned by Stanley Holtzman. As POA, Dr. Holtzman holds voting and dispositive control over such shares. Dr. Holtzman disclaims beneficial ownership of the shares over which he has POA except to the extent of any pecuniary interest therein.
Documents
Issuer
Icosavax, Inc.
CIK 0001786255
Entity typeother
Related Parties
1- filerCIK 0001874371
Filing Metadata
- Form type
- 4
- Filed
- Aug 1, 8:00 PM ET
- Accepted
- Aug 2, 9:42 PM ET
- Size
- 11.7 KB